title: Drug eluting balloons for the treatment of coronary artery disease: What can we expect?
abstract: Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs.
authors.affiliation: Alexander Joost, Volkhard Kurowski, Peter W Radke, Medical Department II, UK S-H Campus Lübeck, University of Lübeck, D-23562 Lübeck, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Joost
authors.forename: Volkhard
authors.initials: V
authors.lastname: Kurowski
authors.forename: Peter W
authors.initials: PW
authors.lastname: Radke